Figures & data
Table 1. Quality of life indices’ change over the study duration.
Figure 1. Quality of Life Indices' Change.
Supplemental material
Postgraduate Medicine
Volume 132, 2020 - Issue 1
Related Research Data
PHARMACOLOGY OF CANNABINOID CB1 AND CB2 RECEPTORS
Source:
Elsevier BV
CBD: Considerations for Use Within the Health System.
Source:
SAGE Publications
Cannabis Use Disorder in Adolescence.
Source:
Elsevier BV
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.
Source:
Springer Science and Business Media LLC
A Prospective Open-label Study
Source:
Ovid Technologies (Wolters Kluwer Health)
Prospects for New Cannabis-Based Prescription Medicines
Source:
Informa UK Limited
(360) Can CBD Reduce the Use of Pain Medication? Lessons from a Survey in a Pain Clinic Environment
Source:
Elsevier BV
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Source:
American Psychiatric Association Publishing
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Source:
Frontiers Media SA
Perspectives on cannabis as a substitute for opioid analgesics.
Source:
Future Medicine Ltd
Cannabis substitution as harm reduction
Source:
Wiley
Linking provided by
